Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date India - Considerations to Improve Patient Outcomes in Early Drug Development Premier Research | Premier Consulting Every drug development program must begin with an understanding of how the relevant key stakeholders factor into the development process. It’s not jus... May 26, 2022 1:00pm PPMO™: Disrupting Biomarker & Target Discovery using AI computational modeling Michael Ritchie, PhD, MBA Learn more about these topics by registering for this webinar: • PPMO™: a novel Pharmaco-Pheno-Multiomic platform which combines AI-powered discovery ... 3 weeks ago | 47 mins Using Data Science to Accelerate Early Drug Discovery with Bayezian and Dataiku 1.) Ossama Shafiq, Clinical Data Scientist @ Bayezian, 2.) Kelci Miclaus, Director of AI Industry Solutions @ Dataiku Join us on this 3 part series where we take you through our production journey. Drug development is a lengthy, complex and costly process, entrenched ... 2 months ago | 59 mins Considerations to Improve Patient Outcomes in Early Drug Development Premier Research | Regulatory Professionals, A Division of Premier Research Every drug development program must begin with an understanding of how the relevant key stakeholders factor into the development process. It’s not jus... 3 months ago | 47 mins AI-enabled predictive retrosynthesis tool to advance drug discovery Dr Abhinav Kumar, Head of Chemistry Solutions, Elsevier & Dr Nilesh Rane, Solution Consultant Life Sciences, Elsevier Rapid navigation of increasingly complex druggable chemical space is critical for innovative drug design. However, chemical synthesis and route design... 9 months ago | 61 mins Accelerating Your Drug Discovery Using Champions' New Platform: Lumin Validate Alexis L. Santana, PhD - Manager, Business Development at Champions Oncology Champions Oncology is illuminating the cellular dynamics of cancer by providing the Lumin platform to accelerate biomarker discovery for all researche... 1 year ago | 38 mins New Medication Risk Score for Polypharmacy-induced Drug-Drug Interactions Jeffrey DiFrancesco, Chief Life Science Officer, Tabula Rasa Healthcare The novel Medication Safety Risk Score quantifies clinically and economically meaningful polypharmacy adverse effects based on pharmacokinetics, pharm... 7 months ago | 47 mins Engineering Integrated Multi-Tissue Platforms for Modeling Human Pathologies Kacey Ronaldson Bouchard, Ph.D., Associate Research Scientist, Columbia University Title: Engineering Integrated Multi-Tissue Platforms for Modeling Systemic Human Pathologies 3D CELL CULTURE SUMMIT MASTER SERIES Bioengineered tiss... 8 months ago | 30 mins DNA-encoded libraries in drug discovery Dr. Alex Satz; Dr. Andreas Brunschweiger DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry to find novel chemical matter that modulates protein targets o... 2 years ago | 78 mins Charting the chemical reaction space for DNA-encoded library design Dr Andreas Brunschweiger, Professor at Chemistry and Chemical Biology of TU Dortmund DNA-encoded libraries (DELs) are a powerful technology for target-based small molecule screening. DEL design raises the question of chemical reaction ... 7 months ago | 49 mins Load more
